Clinical Trial

Mobile Individual Atrial Fibrillation Management Program

Study acronym: m-BAFY
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to develop a mobile individual atrial fibrillation management (m-BAFY) program and to evaluate the effects of the program on symptom severity, medication compliance, self-care agency and quality of life. The main questions that the study aims to answer are as follows; * Is the m-BAFY program effective in symptom control? * Is the m-BAFY program effective in increasing medication compliance? * Is the m-BAFY program effective in improving self-care agency? * Is the m-BAFY program effective in improving quality of life? In order to measure whether m-BAFY is effective, the researchers will download this application to one group's phones, and the other group will not download the application. Participants; * Use this application for 3 months * Patients in the intervention group use the application at least once every two weeks. * Fill in the symptom diary in the application. * Clinical interviews are called for the first interview, at the end of the 1st month and at the end of the 3rd month.
Trial Details
NCT Number NCT06933615
Lead Sponsor Ege University
Collaborators: Ege University Hospital (Application and Research Center)
Conditions Atrial Fibrillation (AF)
Enrollment 90 participants
Start Date 2024-06-10
Primary Completion 2025-01-15 (estimated)
Study Completion 2025-04-15 (estimated)
Updated on ClinicalTrials.gov 2025-04-18